.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Teva
Cipla
Dow
Johnson and Johnson
Cerilliant
UBS
Fish and Richardson
Novartis

Generated: December 12, 2017

DrugPatentWatch Database Preview

VOLTAREN Drug Profile

« Back to Dashboard

Which patents cover Voltaren, and what generic alternatives are available?

Voltaren is a drug marketed by Glaxosmithkline Cons and Novartis and is included in four NDAs.

The generic ingredient in VOLTAREN is diclofenac sodium. There are forty-seven drug master file entries for this compound. Eighty-nine suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ConsVOLTARENdiclofenac sodiumGEL;TOPICAL022122-001Oct 17, 2007ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-002Jul 28, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumSOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-001Jul 28, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVOLTAREN-XRdiclofenac sodiumTABLET, EXTENDED RELEASE;ORAL020254-001Mar 8, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-003Jul 28, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VOLTAREN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
NovartisVOLTARENdiclofenac sodiumSOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-003Jul 28, 1988► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-001Jul 28, 1988► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumTABLET, DELAYED RELEASE;ORAL019201-002Jul 28, 1988► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumSOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991► Subscribe► Subscribe
NovartisVOLTARENdiclofenac sodiumSOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Daiichi Sankyo
Cerilliant
Harvard Business School
Mallinckrodt
UBS
Baxter
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot